| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |